Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major

Diabetic Medicine

Volumn 23, Issue 12, 2006, Pages 1327-1331

  Angelopoulos, N G ^a   Zervas, A ^a   Livadas, S ^b   Adamopoulos, I ^c   Giannopoulos, D ^c   Goula, A ^b   Tolis, G ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b 'Ag Sophia' Children's Hospital   (Greece)

^c Kalamata General Hospital   (Greece)

Author keywords

thalassaemia major; Fasting glycaemia; Glucose tolerance; Homeostasis model assessment

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; IRON OVERLOAD; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL;

ADULT; BETA-THALASSEMIA; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; MALE; MODELS, BIOLOGICAL;

EID: 33746074849     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01988.x     Document Type: Article

References (25)

1. McIntosh N. Endocrinopathy in thalassaemia major. Arch Dis Child 1976; 51: 195-201.
2. Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in β-thalassaemia major. Metabolism 1977; 26: 43-52.
3. Pappas S, Donohue SM, Denver AE, Mohamed-Ali V, Goubet S, Yudkin JS. Glucose intolerance in thalassaemia major is related to insulin resistance and hepatic dysfunction. Metabolism 1996; 45: 652-657.
4. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L et al. Insulin resistance and hyperinsulinemia in homozygous β-thalassaemia. Metabolism 1995; 44: 281-286.
5. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassaemia major. J Clin Endocrinol Metab 1993; 77: 478-483.
6. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA et al. Insulin resistance and hyperinsulinemia in patients with thalassaemia major treated by hypertransfusion. N Engl J Med 1988; 318: 809-814.
7. Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis. A review with some perspectives for the future. Diabetes Metab Rev 1989; 5: 691-709.
8. Olefsky JM. Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms. Adv Exp Med Biol 1993; 334: 129-150.
9. Monge L, Pinach S, Caramellino L, Bertero MT, Dall'omo A, Carta Q. The possible role of autoimmunity in the pathogenesis of diabetes in β-thalassaemia major. Diabetes Metab 2001; 27: 149-54.
10. WHO Study Group. Diabetes mellitus. WHO Tech Rep Series 1985; 727: 1-113.
11. Holl RW, Buck C, Cario H, Wolf A, Thon A, Heinze E et al. Diagnosis of diabetes mellitus in cystic fibrosis and thalassaemia major. Diabetes Care 1998; 21: 671-672.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
13. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37-S42.
15. Angelopoulos N, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D et al. Hypoparathyroidism in transfusion-dependent patients with β-thalassaemia. J Bone Miner Metab 2006; 24: 87-93.
16. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 2003; 162: 139-146.
17. Cario H, Holl R, Debatin K, Kohne E. Disproportionately elevated fasting proinsulin levels in normoglycemic patients with thalassaemia major are correlated to the degree of iron overload. Horm Res 2003; 59: 73-78.
18. Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997; 20: 110-118.
19. Dandona P, Hussain M, Varghese Z, Politis D, Flynn DM, Hoffbrand AV. Insulin resistance and iron overload. Ann Clin Biochem 1983; 20: 77-79.
20. Kattamis CA, Kattamis AC. Management of thalassaemia: growth and development, hormone substitution, vitamin supplementation, and vaccination. Semin Hematol 1995; 32: 269-279.
21. Angelopoulos NG, Goula A, Dimitriou E, Tolis G. Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis. Fertil Steril 2005; 84: 1744.
22. Angelopoulos NG, Goula AK, Papanikolaou G, Tolis G. Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 2006; 17: 150-155.
23. Livadas DP, Economou E, Sofroniadou K, Fotiadou-Pappa H, Van Melle GD, Temler E et al. A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme. Clin Endocrinol 1987; 27: 485-490.
24. Verma RS, Babu A, eds. Human Chromosomes: Principles and Techniques, 2nd edn. New York: McGraw-Hill Inc., 1995.
25. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes 2004; 5: 126-132.